Align Technology | ALGN - Le Bénéfice D'Exploitation





Le Bénéfice D'Exploitation Changement Date
3M USD 1.55B 337M 2026-03
Align Technology USD 178.05M 46.66M 2026-03
Becton, Dickinson and Co. USD 627M 36M 2026-03
Bruker USD 10.2M 66.1M 2026-03
Cardinal Health USD 861M 98M 2026-03
Charles River Laboratories USD 119.9M 44.08M 2026-03
Cooper Companies USD -31M 243.8M 2026-03
CVS Health USD 4.68B 2.57B 2026-03
Danaher USD 1.34B 158M 2026-03
Dentsply International USD 32M 506M 2026-03
Dexcom USD 255.3M 67.7M 2026-03
Henry Schein USD 182M 4M 2026-03
Idexx Laboratories USD 362.59M 46.98M 2026-03
Insulet USD 122M 24.3M 2026-03
Integra LifeSciences USD 11.47M 54.54M 2026-03
IQVIA Holdings USD 565M 2.11B 2026-03
McKesson USD 1.84B 181M 2026-03
Mettler Toledo International USD 233.93M 118M 2026-03
Revvity USD 82.77M 63.06M 2026-03
Solventum Corp USD 85M 20M 2026-03
Stryker USD 1.1B 867M 2026-03
Teleflex USD 37.03M 686K 2026-03
Thermo Fisher Scientific USD 1.91B 389M 2026-03
Veeva Systems USD 273.11M 27.24M 2026-03
Waters USD 148M 122.52M 2026-03
Zimmer Biomet Holdings USD 395.1M 92.2M 2026-03
Zoetis USD 865M 30M 2026-03